Prognostic value of HER2 on breast cancer survival.

Abstract Poster

Authors

null

Nora Katzorke

Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Nora Katzorke , Brigitte Kathrin Rack , Lothar Haeberle , Julia Katharina Neugebauer , Carola Anna Melcher , Carsten Hagenbeck , Helmut Forstbauer , Hans Ulrich Ulmer , Ulrike Soeling , Rolf Kreienberg , Tanja N. Fehm , Andreas Schneeweiss , Matthias W. Beckmann , Peter A. Fasching , Wolfgang Janni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

HER2+

Citation

J Clin Oncol 31, 2013 (suppl; abstr 640)

DOI

10.1200/jco.2013.31.15_suppl.640

Abstract #

640

Poster Bd #

13G

Abstract Disclosures

Similar Posters

First Author: M. A. Shah

Poster

2023 ASCO Annual Meeting

Do HER2 low tumors have a distinct clinicopathologic phenotype?

Do HER2 low tumors have a distinct clinicopathologic phenotype?

First Author: Natália Polidorio

First Author: Daisuke Takahari

First Author: Antonino Musolino